已核实 DOI 相关产品: 0

Boosting tumor treatment by dredging the hurdles of chemodynamic therapy synergistic ion therapy

Journal 2021 · IF 13.273 · 发表于 2021 年 1 月 9 日
作者: Junjie Liu,Yajie Jin,Zan Song,Lihua Xu,Yue Yang,Xiu Zhao,Binghua Wang,Wei Liu,Kaixiang Zhang,Zhenzhong Zhang,Jinjin Shi
阅读全文 在 PubMed 查看

摘要

Although chemodynamic therapy (CDT) holds the advantage of tumor treatment by generating hydroxyl radicals (·OH) without the participation of O 2 , insufficient H 2 O 2 and the hindered Fe ion circulation remain major hurdles for its clinical application. Herein, we developed a hybrid nanoparticle with H 2 O 2 self-supply and iron ion self-circulation properties for enhanced CDT. Through encapsulation of CaO 2 with ZIF-8 and in situ assembled Fe 3+ /TA (tannic acid) on the surface, the hybrid nanoparticles (CaO 2 @ [email protected] ) were prepared. The Fe 3+ /TA coating could dissociate in response to lysosomal acidity, and release Fe 3+ and TA subsequently. Significantly, the unprotected CaO 2 can be degraded to H 2 O 2 and Ca 2+ , providing sufficient materials for CDT and resulting in a Ca 2+ “storm” for ion therapy. Meanwhile, TA could convert Fe 3+ to Fe 2+ , realizing a self-circulation for promoting the sustained generation of ·OH. Interestingly, Fe 3+ /TA coating endows the nanoparticles with photothermal property, which accelerated the degradation and further improved the efficiency of Fenton reaction, obtaining 77.7% of tumor growth inhibited rate without obvious adverse effect in tumor-bearing mice. Our findings showed CaO 2 @ [email protected] had potential to be applied for enhanced CDT synergistic antitumor ion therapy.